Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Cg Oncology Inc’s stock clocked out at $29.61, up 5.86% from its previous closing price of $27.97. In other words, the price has increased by $5.86 from its previous closing price. On the day, 1.02 million shares were traded. CGON stock price reached its highest trading level at $29.69 during the session, while it also had its lowest trading level at $28.4.
Ratios:
To gain a deeper understanding of CGON’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 35.32 and its Current Ratio is at 35.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $60.
On September 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $66.RBC Capital Mkts initiated its Outperform rating on September 23, 2024, with a $66 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 13 ’25 when POST LEONARD E sold 1,000 shares for $29.66 per share. The transaction valued at 29,660 led to the insider holds 0 shares of the business.
Song Hong Fang sold 700,000 shares of CGON for $19,600,000 on Dec 16 ’24. The Director now owns 3,003,931 shares after completing the transaction at $28.00 per share. On Dec 16 ’24, another insider, POST LEONARD E, who serves as the Director of the company, sold 1,000 shares for $28.84 each. As a result, the insider received 28,840 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2254200320 and an Enterprise Value of 1462100736. For the stock, the TTM Price-to-Sale (P/S) ratio is 3315.00 while its Price-to-Book (P/B) ratio in mrq is 3.73. Its current Enterprise Value per Revenue stands at 2137.574 whereas that against EBITDA is -15.24.
Stock Price History:
The Beta on a monthly basis for CGON is 1.29, which has changed by -0.24751145 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $50.23, while it has fallen to a 52-week low of $25.77. The 50-Day Moving Average of the stock is -8.77%, while the 200-Day Moving Average is calculated to be -13.97%.
Shares Statistics:
It appears that CGON traded 650.77K shares on average per day over the past three months and 684660 shares per day over the past ten days. A total of 67.54M shares are outstanding, with a floating share count of 44.59M. Insiders hold about 34.07% of the company’s shares, while institutions hold 61.82% stake in the company. Shares short for CGON as of 1735603200 were 6898883 with a Short Ratio of 10.60, compared to 1732838400 on 5267202. Therefore, it implies a Short% of Shares Outstanding of 6898883 and a Short% of Float of 9.140000500000001.
